Results 151 to 160 of about 10,816 (168)

Differential Diagnosis of Waldenström’s Macroglobulinemia and Early Management: Perspectives from Clinical Practice

Blood and Lymphatic Cancer: Targets and Therapy, 2022
Shashank Reddy Cingam, Surbhi Sidana
exaly  

Extended rituximab therapy in Waldenström's macroglobulinemia

Annals of Oncology, 2005
Steven P. Treon, F Preffer
exaly  

Paradoxical increases in serum IgM and viscosity levels following rituximab in Waldenstrom's macroglobulinemia

Annals of Oncology, 2004
Steven P. Treon, Dheiver Santos
exaly  

Risk of second cancers in Waldenström macroglobulinemia

Annals of Oncology, 2012
Marzia Varettoni, Luca Arcaini, E Morra
exaly  

Characterization of familial Waldenström's macroglobulinemia

Annals of Oncology, 2006
O Tournilhac, X Leleu, E Hatjiharissi
exaly  

International prognostic scoring system for Waldenström macroglobulinemia

Blood, 2009
Steven P. Treon, Giampaolo Merlini, Meletios Dimopoulos   +2 more
exaly  

Multicenter Phase 2 Trial of Rituximab for Waldenström Macroglobulinemia (WM): An Eastern Cooperative Oncology Group Study (E3A98)

Leukemia and Lymphoma, 2004
David Vesole, Morie A Gertz, Montserrat Rué i Monné   +2 more
exaly  

Treatment of Waldenstrom's Macroglobulinemia with the Combination of Fludarabine and Cyclophosphamide

Leukemia and Lymphoma, 2003
Christos Papadimitriou, Meletios Dimopoulos, Dimitra Gika   +2 more
exaly  

Treatment of Waldenstrom's Macroglobulinemia with Rituximab: Prognostic Factors for Response and Progression

Leukemia and Lymphoma, 2004
Athanasios Anagnostopoulos, Gerassimos Pangalis, Meletios Dimopoulos   +2 more
exaly  

CXCR4 mutations affect presentation and outcomes in patients with Waldenström macroglobulinemia: A systematic review

Expert Review of Hematology, 2019
Steven P. Treon, Jorge Castillo, Zachary Hunter   +2 more
exaly